^(18)F-FDG PET/CT findings of paratesticular alveolar rhabdomyosarcoma

作     者：Xueqi Chen Jiayin Shou Shanshi Li Yan Fan Jianhua Zhang 

作者机构：Department of Nuclear MedicinePeking University First HospitalBeijingChina Department of Radiation OncologyPeking University First HospitalBeijingChina 

出 版 物：《Cancer Innovation》 (肿瘤创新（英文）)

年 卷 期：2024年第3卷第2期

页      面：68-71页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：Beijing TCM Science and Technology Foundation,Grant/Award Number:JJ-2020-04 Beijing Science and Technology Project,Grant/Award Number:Z181100001618017 Special Fund for Clinical Research of Wu Jieping Medical Foundation,Grant/Award Number:320.6750.2020-6-25 Interdisciplinary Clinical Research Project of Peking University First Hospital,Grant/Award Number:2021CR32 

主　　题：^(18)F-FDG paratesticular alveolar rhabdomyosarcoma PET/CT 

摘      要：Rhabdomyosarcoma(RMS)originates from primitive mesenchymal cells and is the most common soft tissue tumor in childhood.^(18)F-fluoro-deoxyglucose(^(18)F-FDG)positron emission tomography(PET)/computed tomography(CT)has been reported to be valuable in RMS staging and risk *** RMS is a relatively uncommon form of RMS,most of which are of the embryonal histologic *** alveolar RMS is associated with aggressive behavior,high metastatic potential,and poor *** the best of our knowledge,^(18)F-FDG PET/CT imaging findings of paratesticular alveolar RMS have never been ***,we report on a 16-year-old boy s rare paratesticular alveolar RMS with multiple metastases and its findings on^(18)F-FDG PET/*** case also demonstrates the potential value of^(18)F-FDG PET/CT in RMS staging and treatment decisions,and may aid in the differential diagnosis.